Dose-escalating induction chemotherapy supported by lenograstim preceding high-dose consolidation chemotherapy for advanced breast cancer. Selection of the most acceptable regimen to induce maximal tumor response and investigation of the optimal time to collect peripheral blood progenitor cells for haematological rescue after high-dose consolidation chemotherapy
M E Van Hoef, I Baumann, C Lange, T Luft, E A de Wynter, M Ranson, G R Morgenstern, A Yvers, T M Dexter, N G Testa, Anthony Howell
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Dose-escalating induction chemotherapy supported by lenograstim preceding high-dose consolidation chemotherapy for advanced breast cancer. Selection of the most acceptable regimen to induce maximal tumor response and investigation of the optimal time to collect peripheral blood progenitor cells for haematological rescue after high-dose consolidation chemotherapy'. Together they form a unique fingerprint.